Literature DB >> 11553793

Origin of multidrug resistance in cells with and without multidrug resistance genes: chromosome reassortments catalyzed by aneuploidy.

P Duesberg1, R Stindl, R Hehlmann.   

Abstract

Cancer cells and aneuploid cell lines can acquire resistance against multiple unrelated chemotherapeutic drugs that are over 3,000-fold those of normal levels and display spontaneous resistances up to 20-fold of normal levels. Two different mechanisms were proposed for this phenotype: (i) classical mutation of drug metabolizing genes or (ii) chromosome reassortments, catalyzed by cancer- and cell line-specific aneuploidy, which generate, via new gene dosage combinations, a plethora of cancer phenotypes, including drug resistance. To distinguish between these mechanisms, we have asked whether three mouse cell lines can become drug resistant, from which two or three genes have been deleted, and on which multidrug resistance is thought to depend: Mdr1a, Mdr1b, and Mrp1. Because all three lines could acquire multidrug resistance and were aneuploid, whereas diploid mouse cells could not, we conclude that aneuploid cells become drug resistant via specific chromosome assortments, independent of putative resistance genes. We have asked further whether aneuploid drug-resistant Chinese hamster cells revert spontaneously to drug sensitivity in the absence of cytotoxic drugs at the high rates that are typical of chromosome reassortments catalyzed by aneuploidy or at the very low or zero rates (i.e., deletion) of gene mutation. We found that four drug-resistant hamster cell lines reverted to drug sensitivity at rates of about 2-3% per generation, whereas two closely related lines remained resistant under our conditions. Thus, the karyotypic instability generated by aneuploidy emerges as the common source of the various levels of drug resistance of cancer cells: minor spontaneous resistances reflect accidental chromosome assortments, the high selected resistances reflect complex specific assortments, and multidrug resistance reflects new combinations of unselected genes located on the same chromosomes as selected genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11553793      PMCID: PMC58721          DOI: 10.1073/pnas.201398998

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  64 in total

1.  New-age drug meets resistance.

Authors:  F McCormick
Journal:  Nature       Date:  2001-07-19       Impact factor: 49.962

2.  CYTOGENETICS OF MOUSE LEUKEMIA L1210. I. ASSOCIATION OF A SPECIFIC CHROMOSOME WITH DIHYDROFOLATE REDUCTASE ACTIVITY IN AMETHOPTERIN-TREATED SUBLINES.

Authors:  J L BIEDLER; A M ALBRECHT; D J HUTCHISON
Journal:  Cancer Res       Date:  1965-02       Impact factor: 12.701

3.  Correlation of chromosomal and physiologic changes in tumors.

Authors:  T S HAUSCHKA
Journal:  J Cell Physiol Suppl       Date:  1958-12

4.  Cytogenetically marked clones in human fibroblasts cultured from normal subjects.

Authors:  D G Harnden; P A Benn; J M Oxford; A M Taylor; T P Webb
Journal:  Somatic Cell Genet       Date:  1976-01

5.  Mutations affecting adenine phosphoribosyl transferase activity in Chinese hamster cells.

Authors:  L A Chasin
Journal:  Cell       Date:  1974-05       Impact factor: 41.582

6.  Chromosomal variation and the origin of drug-resistant mutants in mammalian cell lines.

Authors:  M Terzi
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

7.  Effect of ploidy and mutagens on bromodeoxyuridine resistance in haploid and diploid frog cells.

Authors:  L Mezger-Freed
Journal:  Nat New Biol       Date:  1972-02-23

8.  Multidrug resistance in breast cancer: a meta-analysis of MDR1/gp170 expression and its possible functional significance.

Authors:  B J Trock; F Leonessa; R Clarke
Journal:  J Natl Cancer Inst       Date:  1997-07-02       Impact factor: 13.506

Review 9.  Molecular cytogenetics of multiple drug resistance.

Authors:  P V Schoenlein
Journal:  Cytotechnology       Date:  1993       Impact factor: 2.058

10.  Aneuploidy vs. gene mutation hypothesis of cancer: recent study claims mutation but is found to support aneuploidy.

Authors:  R Li; A Sonik; R Stindl; D Rasnick; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  33 in total

1.  Chromosomal instability upregulates interferon in acute myeloid leukemia.

Authors:  Ning Jin; Robert F Lera; Rachel E Yan; Fen Guo; Kim Oxendine; Vanessa L Horner; Yang Hu; Jun Wan; Ryan J Mattison; Beth A Weaver; Mark E Burkard
Journal:  Genes Chromosomes Cancer       Date:  2020-07-18       Impact factor: 5.006

2.  Chromosomal instability, tolerance of mitotic errors and multidrug resistance are promoted by tetraploidization in human cells.

Authors:  Anastasia Y Kuznetsova; Katarzyna Seget; Giuliana K Moeller; Mirjam S de Pagter; Jeroen A D M de Roos; Milena Dürrbaum; Christian Kuffer; Stefan Müller; Guido J R Zaman; Wigard P Kloosterman; Zuzana Storchová
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.

Authors:  Wei Li; Yating You; Xiaowei Zhang; Yexun Song; Hong Xiang; Xiaowei Peng; Jiangbo Qin; Guolin Tan
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  2n or not 2n: Aneuploidy, polyploidy and chromosomal instability in primary and tumor cells.

Authors:  Lauren M Zasadil; Eric M C Britigan; Beth A Weaver
Journal:  Semin Cell Dev Biol       Date:  2013-02-13       Impact factor: 7.727

5.  Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.

Authors:  Thomas Dittmar; Sarah Schwitalla; Jeanette Seidel; Sonja Haverkampf; Georg Reith; Sönke Meyer-Staeckling; Burkhard H Brandt; Bernd Niggemann; Kurt S Zänker
Journal:  Clin Exp Metastasis       Date:  2010-10-28       Impact factor: 5.150

Review 6.  Combined HSP90 and kinase inhibitor therapy: Insights from The Cancer Genome Atlas.

Authors:  Harvey Schwartz; Brad Scroggins; Abbey Zuehlke; Toshiki Kijima; Kristin Beebe; Alok Mishra; Len Neckers; Thomas Prince
Journal:  Cell Stress Chaperones       Date:  2015-06-13       Impact factor: 3.667

Review 7.  Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer.

Authors:  Norman Pavelka; Giulia Rancati; Rong Li
Journal:  Curr Opin Cell Biol       Date:  2010-07-23       Impact factor: 8.382

8.  Chromosomal instability determines taxane response.

Authors:  Charles Swanton; Barbara Nicke; Marion Schuett; Aron C Eklund; Charlotte Ng; Qiyuan Li; Thomas Hardcastle; Alvin Lee; Rajat Roy; Philip East; Maik Kschischo; David Endesfelder; Paul Wylie; Se Nyun Kim; Jie-Guang Chen; Michael Howell; Thomas Ried; Jens K Habermann; Gert Auer; James D Brenton; Zoltan Szallasi; Julian Downward
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-19       Impact factor: 11.205

9.  Chromosomal instability confers intrinsic multidrug resistance.

Authors:  Alvin J X Lee; David Endesfelder; Andrew J Rowan; Axel Walther; Nicolai J Birkbak; P Andrew Futreal; Julian Downward; Zoltan Szallasi; Ian P M Tomlinson; Michael Howell; Maik Kschischo; Charles Swanton
Journal:  Cancer Res       Date:  2011-03-01       Impact factor: 12.701

Review 10.  Aneuploidy and drug resistance in pathogenic fungi.

Authors:  Kyung J Kwon-Chung; Yun C Chang
Journal:  PLoS Pathog       Date:  2012-11-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.